The comparison of the performance of two screening strategies identifying newly-diagnosed HIV during pregnancy

European Journal of Public Health

Volumn 21, Issue 5, 2011, Pages 632-637

  Boer, Kees ^a   Smit, Colette ^b   Van Der Flier, Michiel ^c   De Wolf, Frank ^b,d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b STICHTING HIV MONITORING   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

antenatal screening; HIV; mother to child transmission; pregnancy

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE TRANSMISSION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MASS SCREENING; METHODOLOGY; NETHERLANDS; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; RETROSPECTIVE STUDY; UTILIZATION REVIEW; VERTICAL TRANSMISSION;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; FEMALE; HIV; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MASS SCREENING; NETHERLANDS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 80053513153     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckq157     Document Type: Article

References (25)

1. Deblonde J, Claeys P, Temmerman M. Antenatal HIV screening in Europe: a review of policies. Eur J Public Health 2007;17:414-8. (Pubitemid 350034004)
2. Boer K, Nellen JF, Patel D, et al. The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery. BJOG 2007;114:148-55. (Pubitemid 46089443)
3. Townsend CL, Cortina-Borja M, Peckham CS, et al. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 2008;22:973-81. (Pubitemid 351652248)
4. Goetghebuer T, Haelterman E, Marvillet I, et al. Vertical transmission of HIV in Belgium: a 1986-2002 retrospective analysis. Eur J Pediatr 2009;168:79-85.
5. European Collaborative Study, Boer K, England K, Godfried MH, Thorne C. Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe. HIV Med 2010;11:368-78.
6. Van Der Bij AK, Mulder-Folkerts DKF, Van Den Hoek JAR, et al. HIV-screening among pregnant women in the region of Amsterdam in 2002. Nederlands Tijdschrift voor Geneeskunde 2003;147:1232-6. (Pubitemid 36775483)
7. The UK Collaborative Group for HIV and STI Surveillance. Testing Times. HIV and Other Sexually Transmitted Infections in the United Kingdom. London: Health Protection Agency Centre for Infections, 2007, http://www.hpa.org.uk/web/ HPAweb&HPAwebStandard/HPAweb-C/1201871102663 (22 June 2009, date last accessed).
8. Mulder-Folkerts DKF, Van Den Hoek JAR, Van Der Bij AK, et al. HIV screening among pregnant women in the Amsterdam region in 2003 according to the opting-out method. Nederlands Tijdschrift voor Geneeskunde 2004;148:2035-7 (Pubitemid 39362033)
9. College voor zorgverzekeringen (CVZ). Implementatie standard HIV-screening voor zwangere vrouwen. Publicatienr 02/124. Amstelveen: CVZ, 2002.
10. Hughes CA, Zuk D, Foisy M, et al. Prenatal screening and perinatal HIV transmission in Northern Alberta, 1999-2006. Am J Public Health 2009;99(Suppl 2):S412-16.
11. Southgate J, Mital D, Stock A. Are women from high-risk ethnic minority groups more likely to decline antenatal HIV screening? Int J STD AIDS 2008;19:206-67.
12. van Sighem AI, van de Wiel MA, Ghani AC, et al. Mortality and progression to AIDS after starting highly active antiretroviral therapy. AIDS 2003;17:2227-36. (Pubitemid 37338896)
13. Werkgroep Antiretrovirale.Werkgroep antiretrovirale behandeling van de Nederlandse Vereniging van AIDS Behandelaren [Revised guidelines "Antiretroviral Treatment"]. Ned Tijdschr Geneeskd, 2005. 149, 2399-405.
14. Volmink J, Siegfried NL, van der Merwe L, et al. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev 2007;1:CD003510.
15. Mahajan AP, Stemple L, Shapiro MF, et al. Consistency of state statutes with the Centers for Disease Control and Prevention HIV testing recommendations for health care settings. Ann Intern Med 2009;150:263-9.
16. Plitt SS, Singh AE, Lee BE, et al. HIV seroprevalence among women opting out of prenatal HIV screening in Alberta, Canada: 2002-2004. Clin Infect Dis 2007;45:1640-3. (Pubitemid 351411851)
17. Yudin MH, Moravac C, Shah RR. Influence of an "opt-out" test strategy and patient factors on human immunodeficiency virus screening in pregnancy. Obstet Gynecol 2007;110:81-6. (Pubitemid 47015704)
18. Creek TL, Ntumy R, Seipone K, et al. Successful introduction of routine opt-out HIV testing in antenatal care in Botswana. J Acquir Immune Defic Syndr 2007;45:102-7. (Pubitemid 46684449)
19. Podhurst LS, Storm DS, Dolgonos S. Women's opinions about routine HIV testing during pregnancy: implications for the opt-out approach. AIDS Patient Care STDS 2009;23:331-7.
20. Statistics Netherlands 2010, http://www.cbs.nl.
21. Moses SE, Tosswill J, Sudhanva M, et al. HIV-1 seroconversion during pregnancy resulting in vertical transmission. J Clin Virol 2008;41:152-3. (Pubitemid 351179452)
22. Patterson KB, Leone PA, Fiscus SA, et al. Frequent detection of acute HIV infection in pregnant women. AIDS 2007;21:2303-8. (Pubitemid 350287456)
23. Moodley D, Esterhuizen TM, Pather T, et al. High HIV incidence during pregnancy: compelling reason for repeat HIV testing. AIDS 2009;23:1255-9.
24. Kissin DM, Akatova N, Rakhmanova AG, et al. Rapid HIV testing and prevention of perinatal HIV transmission in high-risk maternity hospitals in St. Petersburg, Russia. Am J Obstet Gynecol 2008;198:183.e1-7.
25. Brou H, Djohan G, Becquet R, et al. Sexual prevention of HIV within the couple after prenatal HIV-testing in West Africa. AIDS Care 2008;20:413-8. (Pubitemid 351652490)